Toral KJ, Wuenschel MA, Black EP. Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors. PLoS One 2021;16:e0256416.
PMID: 34437586